Next Step For FDA's 'Case For Quality'? 8 New Guidance Docs
This article was originally published in The Gray Sheet
Device manufacturers and FDA investigators reported generally positive experiences with FDA’s "critical-to-quality" inspection pilot, but the agency has decided to shift the focus to producing eight new guidance documents to better suit the project’s mission.
You may also be interested in...
At The Intersection Of Quality And Metrics: What's Ahead In FDA’s Effort To More Objectively Measure Quality
Quality metrics are being developed by the US FDA to not only determine which medical device facilities to inspect next, but to also raise firms' overall approach to quality above baseline. In-process metrics work by the Medical Device Innovation Consortium will be used as the agency comes up with its own robust set of measurements. Meanwhile, FDA is gearing up for a new pilot program targeting 10-20 device manufacturers that will submit quality data to the agency; MDIC explains how to calculate its three quality metrics; and quality officials from Baxter, J&J and Stryker weigh in.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.
Novartis’s first digital innovation hub in Asia is launched in India, where the Swiss company hopes to ally with partners to deliver digital solutions for patients at scale.